Michael E. Beil
Impact in
-
- Hormonal Regulation and Hypertension
- Adrenal Hormones and Disorders
- Physiology top 10%
- Nitric Oxide and Endothelin Effects
- Adenosine and Purinergic Signaling
Papers in
-
- Renin-Angiotensin System Studies 5
- Heart Failure Treatment and Management 5
- Physiology 11
- Nitric Oxide and Endothelin Effects 10
- Co-authors
- Arco Y. Jeng (15 shared papers)Dean F. Rigel (9 shared papers)Fumin Fu (7 shared papers)Nigel Levens (2 shared papers)Angelo J. Trapani (13 shared papers)Charles W. Bruseo (10 shared papers)James L. Bergey (1 shared paper)Guiqing Liang (4 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (8 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Clinical Science (2 papers)ACS Medicinal Chemistry Letters (2 papers)
- Partner nations
- SwitzerlandUnited StatesChina
In The Last Decade
Michael E. Beil
32 papers receiving 607 citations
Peers
Comparison fields: 5 of 80
- Endocrinology, Diabetes and Metabolism 187
- Physiology 44
- Pharmacology 64
- Cardiology and Cardiovascular Medicine 134
- Biochemistry 36
Countries citing papers authored by Michael E. Beil
This map shows the geographic impact of Michael E. Beil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Beil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Beil more than expected).
Fields of papers citing papers by Michael E. Beil
This network shows the impact of papers produced by Michael E. Beil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Beil. The network helps show where Michael E. Beil may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Beil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 117 | |
| 2 | 2010 | 51 | |
| 3 | 2014 | 49 | |
| 4 | 1991 | 43 | |
| 5 | 2013 | 42 | |
| 6 | 2015 | 32 | |
| 7 | 2014 | 31 | |
| 8 | 1983 | 27 | |
| 9 | 2015 | 26 | |
| 10 | 2013 | 24 | |
| 11 | 2000 | 20 | |
| 12 | 2005 | 19 | |
| 13 | 2000 | 19 | |
| 14 | 2013 | 13 | |
| 15 | 2002 | 13 | |
| 16 | 2004 | 13 | |
| 17 | 2000 | 11 | |
| 18 | 2000 | 11 | |
| 19 | 2002 | 10 | |
| 20 | 1991 | 9 |
About Michael E. Beil
Michael E. Beil is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Endocrinology, Diabetes and Metabolism, Pharmacology and Molecular Biology, having authored 32 papers that have together received 642 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (10 papers), Hormonal Regulation and Hypertension (6 papers), Renin-Angiotensin System Studies (5 papers), Peptidase Inhibition and Analysis (5 papers), Heart Failure Treatment and Management (5 papers), Phosphodiesterase function and regulation (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (187 citations), Physiology (44 citations), Pharmacology (64 citations), Cardiology and Cardiovascular Medicine (134 citations) and Biochemistry (36 citations). Michael E. Beil has collaborated with scholars based in Switzerland, United States and China. Frequent co-authors include Arco Y. Jeng, Dean F. Rigel, Fumin Fu, Nigel Levens, Angelo J. Trapani, Charles W. Bruseo, James L. Bergey, Guiqing Liang, Paula Savage and Stéphane De Lombaert. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry Letters, Clinical Science and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.